P-Smad3 Differentially Regulates the Cytological Behavior of Osteoclasts Before and After Osteoblasts Maturation

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2024 Apr 17

PMID 38632128

Authors

Jiapeng Ye

Zhen Hua

Jirimutu Xiao

Yang Shao

Shaoshuo Li

Heng Yin

Mao Wu

Yi Rong

Bowen Hong

Yang Guo

Yong Ma

Jianwei Wang

Affiliations

Soon will be listed here.

Abstract

Background: A series of previous investigations have revealed that p-Smad3 plays a facilitative role in the differentiation and maturation of osteoblasts, while also regulating the expression of certain intercellular communication factors. However, the effects of p-Smad3 in osteoblasts before and after maturation on the proliferation, migration, differentiation, apoptosis and other cellular behaviors of osteoclasts have not been reported.

Methods: MC3T3-E1 cells were cultured in osteogenic induction medium for varying durations, After that, the corresponding conditioned medium was collected and the osteoclast lineage cells were treated. To elucidate the regulatory role of p-Smad3 within osteoblasts, we applied the activator TGF-β1 and inhibitor SIS3 to immature and mature osteoblasts and collected corresponding conditioned media for osteoclast intervention.

Results: We observed an elevation of p-Smad3 and Smad3 during the early stage of osteoblast differentiation, followed by a decline in the later stage. we discovered that as osteoblasts mature, their conditioned media inhibit osteoclasts differentiation and the osteoclast-coupled osteogenic effect. However, it promotes apoptosis in osteoclasts and the angiogenesis coupled with osteoclasts. p-Smad3 in immature osteoblasts, through paracrine effects, promotes the migration, differentiation, and osteoclast-coupled osteogenic effects of osteoclast lineage cells. For mature osteoblasts, p-Smad3 facilitates osteoclast apoptosis and the angiogenesis coupled with osteoclasts.

Conclusions: As pre-osteoblasts undergo maturation, p-Smad3 mediated a paracrine effect that transitions osteoclast cellular behaviors from inducing differentiation and stimulating bone formation to promoting apoptosis and coupling angiogenesis.

References

Kular J, Tickner J, Chim S, Xu J . An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 2012; 45(12):863-73. DOI: 10.1016/j.clinbiochem.2012.03.021. View

Pederson L, Ruan M, Westendorf J, Khosla S, Oursler M . Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008; 105(52):20764-9. PMC: 2603259. DOI: 10.1073/pnas.0805133106. View

Ikebuchi Y, Aoki S, Honma M, Hayashi M, Sugamori Y, Khan M . Coupling of bone resorption and formation by RANKL reverse signalling. Nature. 2018; 561(7722):195-200. DOI: 10.1038/s41586-018-0482-7. View

Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L . PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014; 20(11):1270-8. PMC: 4224644. DOI: 10.1038/nm.3668. View

Rindone A, Liu X, Farhat S, Perdomo-Pantoja A, Witham T, Coutu D . Quantitative 3D imaging of the cranial microvascular environment at single-cell resolution. Nat Commun. 2021; 12(1):6219. PMC: 8553857. DOI: 10.1038/s41467-021-26455-w. View

Kawakatsu M, Kanno S, Gui T, Gai Z, Itoh S, Tanishima H . Loss of Smad3 gives rise to poor soft callus formation and accelerates early fracture healing. Exp Mol Pathol. 2010; 90(1):107-15. DOI: 10.1016/j.yexmp.2010.10.011. View

Cheung K, Sposito N, Stumpf P, Wilson D, Sanchez-Elsner T, Oreffo R . MicroRNA-146a regulates human foetal femur derived skeletal stem cell differentiation by down-regulating SMAD2 and SMAD3. PLoS One. 2014; 9(6):e98063. PMC: 4043645. DOI: 10.1371/journal.pone.0098063. View

Lin H, Chen S, Guo J, Su I, Huang C, Chien C . Dynamic expression of SMAD3 is critical in osteoblast differentiation of PDMCs. Int J Mol Med. 2018; 43(2):1085-1093. DOI: 10.3892/ijmm.2018.4001. View

Lou Z, Yang Y, Ren T, Tang S, Peng X, Lu Q . Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. Med Oncol. 2013; 30(3):606. DOI: 10.1007/s12032-013-0606-8. View

10.

Xu Z, Greenblatt M, Yan G, Feng H, Sun J, Lotinun S . SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Nat Commun. 2017; 8:14570. PMC: 5321737. DOI: 10.1038/ncomms14570. View

11.

Inoue M, Nagai-Yoshioka Y, Yamasaki R, Kawamoto T, Nishihara T, Ariyoshi W . Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-β1 via the ubiquitin-proteasome system. PLoS One. 2022; 17(2):e0262612. PMC: 8865688. DOI: 10.1371/journal.pone.0262612. View

12.

Zhu S, Ehnert S, Rouss M, Haussling V, Aspera-Werz R, Chen T . From the Clinical Problem to the Basic Research-Co-Culture Models of Osteoblasts and Osteoclasts. Int J Mol Sci. 2018; 19(8). PMC: 6121694. DOI: 10.3390/ijms19082284. View

13.

Kang H, Jha S, Ivovic A, Fratzl-Zelman N, Deng Z, Mitra A . Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway. J Exp Med. 2020; 217(5). PMC: 7201932. DOI: 10.1084/jem.20191499. View

14.

Tang C, Liang D, Qiu Y, Zhu J, Tang G . Omentin‑1 induces osteoblast viability and differentiation via the TGF‑β/Smad signaling pathway in osteoporosis. Mol Med Rep. 2022; 25(4). PMC: 8867465. DOI: 10.3892/mmr.2022.12648. View

15.

Yang L, Hai Y, Zhou J . Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. Chin Med J (Engl). 2011; 124(13):2033-7. View

16.

Tang X, Han J, Meng H, Zhao Y, Wang H, Liu J . Downregulation of RANKL and RANKL/osteoprotegerin ratio in human periodontal ligament cells during their osteogenic differentiation. J Periodontal Res. 2015; 51(1):125-32. DOI: 10.1111/jre.12291. View

17.

Gori F, Hofbauer L, Dunstan C, Spelsberg T, Khosla S, Riggs B . The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology. 2000; 141(12):4768-76. DOI: 10.1210/endo.141.12.7840. View

18.

Park H, Son Y, Lee S, Rho G, Kang Y, Park B . Effects of Osteogenic-Conditioned Medium from Human Periosteum-Derived Cells on Osteoclast Differentiation. Int J Med Sci. 2017; 14(13):1389-1401. PMC: 5707756. DOI: 10.7150/ijms.21894. View

19.

Doi T, Hioki T, Tachi J, Ueda K, Matsushima-Nishiwaki R, Iida H . Oncostatin M reduces the synthesis of macrophage-colony stimulating factor stimulated by TGF-β via suppression of p44/p42 MAP kinase and JNK in osteoblasts. Biomed Res. 2022; 43(2):41-51. DOI: 10.2220/biomedres.43.41. View

20.

Li J, Ayoub A, Xiu Y, Yin X, Sanders J, Mesfin A . TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis. Nat Commun. 2019; 10(1):2795. PMC: 6595054. DOI: 10.1038/s41467-019-10677-0. View